
21.01.2020
Genekam has developed novel corona virus 2020 (Wuhan strain specific) kits and potential therapeutic molecules.
21.01.2020
3D Genomemedicine Inc is going to operate in USA
Duissernstr. 65a
47058 Duisburg
Germany
Tel.:+49 203 / 555 858 -31 / 32 / 33
mobil: +49 (0)170 / 3503779 (WhatsApp Messenger)
Fax: +49 203 / 35 82 99
E-Mail: anfrage@genekam.de
Skype: genekam-biotechnology